CausalSentinel

Protein Dossier — APMAP (Adipocyte plasma membrane-associated protein)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Body mass index (BMI) 0.04 0.0122 0.00109 Wald ratio 1 cis NA
Heel bone mineral density (BMD) T-score automated -0.0444 0.0159 0.00517 Wald ratio 1 cis NA
Creatinine (enzymatic) in urine 0.0327 0.0117 0.00526 Wald ratio 1 cis NA
Weight 0.0288 0.0108 0.00782 Wald ratio 1 cis NA
ER-positive Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.105 0.0411 0.0105 Wald ratio 1 cis NA
Non-cancer illness code self-reported: kidney stone or ureter stone or bladder stone 0.271 0.107 0.0115 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) -0.0836 0.0344 0.015 Wald ratio 1 cis NA
Diagnoses - main ICD10: G56 Mononeuropathies of upper limb 0.177 0.0786 0.024 Wald ratio 1 cis NA
Serum cystatin C (eGFRcys) -0.0206 0.00944 0.0294 Wald ratio 1 cis NA
Diagnoses - main ICD10: K29 Gastritis and duodenitis -0.208 0.0988 0.0353 Wald ratio 1 cis NA
Diagnoses - main ICD10: Z09 Follow-up examination after treatment for conditions other than malignant neoplasms -0.277 0.134 0.0393 Wald ratio 1 cis NA
Sodium in urine 0.0244 0.0121 0.0429 Wald ratio 1 cis NA
…and 90 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

27 association rows across 21 traits (24 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Serum levels of protein CST7 3e-171 rs113136783 2 GCST90087734 no MR -> candidate analysis
Cystatin-F levels 6e-151 rs185515630 3 GCST90161700 no MR -> candidate analysis
APMAP protein levels 9e-128 rs12242 2 GCST90453381 no MR -> candidate analysis
CST7 protein levels 8e-107 rs79304811 2 GCST90468897 no MR -> candidate analysis
Eosinophil side scatter 5e-69 rs6114984 1 GCST90281230 no MR -> candidate analysis
Cystatin-F levels (CST7.3302.58.1) 9e-62 rs185515630 1 GCST90240832 no MR -> candidate analysis
Acetate levels 6e-41 rs6138465 1 GCST90092803 no MR -> candidate analysis
Serum levels of protein APMAP 3e-32 rs12242 1 GCST90086361 no MR -> candidate analysis
Eosinophil forward scatter 2e-31 rs56312312 1 GCST90281232 no MR -> candidate analysis
APMAP protein level (protein group normalized intensity) 7e-22 rs6138438 1 GCST90570806 no MR -> candidate analysis
Smoking initiation 4e-18 rs6050215 2 GCST90243968 no MR -> candidate analysis
Adipocyte plasma membrane-associated protein levels (APMAP.1 3e-16 rs8125909 1 GCST90240199 no MR -> candidate analysis
…and 9 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 447 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
smoking initiation 0.439 common-variant locus no MR -> candidate analysis
obesity disorder 0.354 common-variant locus no MR -> candidate analysis
ovarian dysfunction 0.08 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Adipocyte plasma membrane-associated protein)
gnomAD constraint pLI=3.5e-09, LOEUF=1.01 — LoF-tolerant
GWAS Catalog 87 unique SNPs / 174 rows
ClinVar 116 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance